Skip to main content
Nath Biogene India Ltd. logo

Nath Biogene India Ltd. — Investor Relations & Filings

Ticker · NATHBIOGEN ISIN · INE448G01010 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 450 across all filing types
Latest filing 2026-01-31 Regulatory Filings
Country IN India
Listing BSE.NS NATHBIOGEN

About Nath Biogene India Ltd.

https://www.nathbiogenes.com

Nath Biogene India Ltd. specializes in the research, development, production, and marketing of high-quality hybrid seeds. The company maintains a diverse product portfolio encompassing field crops such as cotton, paddy, maize, jowar, and bajra, alongside a wide range of vegetable seeds including tomato, okra, and chili. With a strong emphasis on biotechnological innovation and plant breeding, the organization focuses on developing high-yielding, pest-resistant, and climate-resilient seed varieties to enhance agricultural productivity. Its operations are supported by extensive research and development facilities and a robust distribution network that ensures the delivery of advanced genetic materials to farming communities. The company leverages its technical expertise to provide integrated solutions aimed at improving crop quality and farmer profitability through sustainable agricultural practices.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of a duplicate share certificate due to the original being lost. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 39(3), which pertains to share certificate management. The content is about a specific share certificate replacement and does not contain financial results, management discussion, or regulatory filings beyond this notification. It is not an annual report, earnings release, or any detailed financial or governance report. It is also not a voting result or capital change announcement. The document is a regulatory announcement related to share certificate issuance, which fits best under Regulatory Filings (RNS) as it is a compliance notification without substantive financial data or report content.
2026-01-31 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-24 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the unaudited financial results for the quarter and nine months ended 31st December 2025. It is an intimation to stock exchanges as per SEBI Listing Regulations. The document does not contain the financial results themselves, only the announcement of the meeting and the agenda to approve those results. The document length is short (1662 characters) and it is clearly an announcement rather than the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about an upcoming board meeting and financial results approval.
2026-01-24 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st December 2025. It is a formal certificate from the Registrar and Share Transfer Agent confirming compliance related to dematerialization of securities and updating the register of members. The document is short (2946 characters) and serves as a regulatory compliance submission rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is not an announcement of a report publication but the certificate itself. This fits best under Regulatory Filings (RNS), which covers compliance documents and miscellaneous regulatory filings that do not fit other categories.
2026-01-20 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window in compliance with SEBI regulations ahead of the announcement of unaudited financial results for the quarter and nine months ended December 31, 2025. It does not contain any financial data or results itself, nor does it provide detailed financial analysis or report. It is an announcement related to insider trading restrictions prior to the release of quarterly financial results. Given the short length (1508 characters) and the nature of the content, this is not a financial report but a regulatory announcement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-12-27 English
Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of a conference call held by Nath Bio-Genes (India) Limited on November 14, 2025, discussing the company's Q2 and half-year financial results for FY 2026. It includes management commentary on operational performance, financial highlights, business outlook, and a Q&A session with analysts. The presence of detailed financial data, management discussion, and Q&A indicates this is a full earnings call transcript rather than a brief earnings release or presentation. The document explicitly mentions it is an "Earnings Conference Call" and contains the full text of the call, including management remarks and analyst questions. Therefore, the appropriate classification is Call Transcript (CT).
2025-11-18 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.